Back
ESC Premium Access

Future direction for research in therapeutic modulation of the immune response in atherosclerosis.

Session: Therapeutic modulation of the immune response in atherosclerosis
Topic: Atherosclerosis
Speaker: Professor J. Nilsson (Malmo, SE)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Professor Jan Nilsson

Lund University, Malmo (Sweden)
2 presentations
0 follower

4 more presentations in this session

State of the art in therapeutic modulation of the immune response in atherosclerosis

Speaker: Professor P. Libby (Boston, US)

Access
Like
Thumbnail

Nanoparticle-enabled RNAi in endothelial cells attenuates inflammation in atherosclerosis and acute myocardial infarction

Speaker: Doctor H. Sager (Munich, DE)

Access
Abstract
Like
Thumbnail

STAT4 deficiency exacerbates atherosclerosis by promoting mobilization of myeloid cells, polarization of M1 macrophages and formation of foam cells

Speaker: Doctor L. Xu (Shanghai, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Bone marrow-specific Sirt6 deletion enhances atherosclerosis and foam cell formation via an increase in macrophage scavenger receptor 1 expression

Speaker: Miss T. Arsiwala (Zurich, CH)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Therapeutic modulation of the immune response in atherosclerosis

Speakers: Professor J. Nilsson, Professor P. Libby, Doctor H. Sager, Doctor L. Xu, Miss T. Arsiwala
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources